Invesco’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.74M | Sell |
70,888
-183,598
| -72% | -$25.2M | ﹤0.01% | 1786 |
|
2025
Q1 | $45.9M | Sell |
254,486
-20,709
| -8% | -$3.73M | 0.01% | 1071 |
|
2024
Q4 | $43.1M | Sell |
275,195
-90,356
| -25% | -$14.2M | 0.01% | 1115 |
|
2024
Q3 | $66.5M | Buy |
365,551
+90,474
| +33% | +$16.5M | 0.01% | 931 |
|
2024
Q2 | $50.5M | Buy |
275,077
+185,449
| +207% | +$34.1M | 0.01% | 1006 |
|
2024
Q1 | $15.9M | Buy |
89,628
+35,399
| +65% | +$6.3M | ﹤0.01% | 1560 |
|
2023
Q4 | $6.73M | Buy |
54,229
+10,030
| +23% | +$1.24M | ﹤0.01% | 2070 |
|
2023
Q3 | $5.13M | Sell |
44,199
-21,009
| -32% | -$2.44M | ﹤0.01% | 2194 |
|
2023
Q2 | $7.66M | Buy |
65,208
+13,628
| +26% | +$1.6M | ﹤0.01% | 1988 |
|
2023
Q1 | $4.13M | Buy |
51,580
+23,537
| +84% | +$1.88M | ﹤0.01% | 2309 |
|
2022
Q4 | $2.22M | Sell |
28,043
-23,565
| -46% | -$1.87M | ﹤0.01% | 2595 |
|
2022
Q3 | $3.6M | Buy |
51,608
+42,454
| +464% | +$2.96M | ﹤0.01% | 2373 |
|
2022
Q2 | $600K | Buy |
9,154
+1,404
| +18% | +$92K | ﹤0.01% | 3222 |
|
2022
Q1 | $515K | Buy |
7,750
+69
| +0.9% | +$4.59K | ﹤0.01% | 3341 |
|
2021
Q4 | $538K | Sell |
7,681
-455
| -6% | -$31.9K | ﹤0.01% | 3323 |
|
2021
Q3 | $425K | Buy |
8,136
+931
| +13% | +$48.6K | ﹤0.01% | 3472 |
|
2021
Q2 | $489K | Buy |
7,205
+3,454
| +92% | +$234K | ﹤0.01% | 3405 |
|
2021
Q1 | $289K | Buy |
+3,751
| New | +$289K | ﹤0.01% | 3546 |
|
2020
Q2 | – | Sell |
-34,701
| Closed | -$1.5M | – | 3625 |
|
2020
Q1 | $1.5M | Sell |
34,701
-47,632
| -58% | -$2.06M | ﹤0.01% | 2543 |
|
2019
Q4 | $4.56M | Buy |
82,333
+35,123
| +74% | +$1.95M | ﹤0.01% | 2215 |
|
2019
Q3 | $1.64M | Buy |
+47,210
| New | +$1.64M | ﹤0.01% | 2717 |
|
2019
Q1 | – | Sell |
-47,113
| Closed | -$979K | – | 3706 |
|
2018
Q4 | $979K | Buy |
+47,113
| New | +$979K | ﹤0.01% | 2971 |
|